July 23, 2014 6:29 PM ET

Pharmaceuticals

Company Overview of Forest Laboratories, Inc.

Company Overview

As of July 1, 2014, Forest Laboratories, Inc. was acquired by Actavis plc. Forest Laboratories, Inc. is a specialty pharmaceutical company and develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. Its products include Fetzima and Viibryd for the treatment of major depressive disorder; Linzess to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Tudorza Pressair, an antimuscarinic agent for the treatment of bronchospasm associated with chronic obstructive pulmonary disease. The company also provides Namenda IR and Namenda XR for moderate to severe dementia of the Alzheimer’s type; Daliresp, a phosphodi...

909 Third Avenue

New York, NY 10022

United States

Founded in 1954

6,200 Employees

Phone:

212-421-7850

Key Executives for Forest Laboratories, Inc.

Forest Laboratories, Inc. does not have any Key Executives recorded.

Forest Laboratories, Inc. Key Developments

Forest Laboratories Inc.(NYSE:FRX) dropped from Russell 1000 Index

Forest Laboratories Inc. will be removed from the Russell 1000 Index.

Forest Laboratories Inc.(NYSE:FRX) dropped from Russell 3000 Index

Forest Laboratories Inc. will be removed from the Russell 3000 Index.

Forest Mulls Acquisitions

Forest Laboratories Inc. is seeking acquisition opportunities. Forest focus on deals for now will be on building up the brand-name drug side, Brent Saunders, Chief Executive Officer of Forest, said. Forest will spend about $400 million a year on research and development inside Forest, with more for outside acquisitions, he added.

Similar Private Companies By Industry

Company Name Region
AAH Group, Inc. United States
Virdante Pharmaceuticals, Inc. United States
Immune Modulation, Inc. United States
Sirena Therapeutics, Inc. United States
AstraZeneca LP United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 28, 2014
Furiex Pharmaceuticals, Inc.
Merger/Acquisition
February 18, 2014
--
Merger/Acquisition
February 12, 2014
Forest Laboratories, Inc., ESGIC, ESGIC PLUS, LORCET, and LORCET PLUS Brands
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Forest Laboratories, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.